OGN News and Press, Organon & Co. From 11/08/21

NEXPLANON® (etonogestrel extended-release subdermal implant) Now Covered by Quebec's Public Formulary Canada NewsWire Public reimbursement is effective on November 10 th . KIRKLAND, QC , Nov. 8, 2021 /CNW/ - Organon (NYSE: OGN) is pleased to ...

FMC Corporation and Sabra Healthcare are the new additions reviewed using FASTgraphs and relating future potential. The complete list of add ons and trims are shown with prices, costs and the resulting effect to Rose portfolio “RIG” 2022 income. The 4 honorable menti...

Kahn Brothers’ 13F portfolio value increased from $698M to $710M this quarter. Pfizer, VOXX International, and ViewRay were increased substantially during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~44% of the 13F...

Victoria's Secret is a spin-off from L Brands. The company is trading for an extremely attractive valuation. Spin-off companies tend to outperform the market. For further details see: Spin-Off Companies Outperforms The Market The Case For Victoria's Secret

Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET. Interested parties may access the live call via webcast on the Organon website at https://www.orga...

This Buffett holdings list from Kiplinger first appeared 8/17/21 online. YCharts and Dogs of The Dow also track this Buffett/Berkshire Batch. Here is your update from 10/13/21 YCharts data. 29 of 44 current Berkshire-Hathaway-owned stocks pay dividends. As of 10/13/21 the top-ten rang...

Website aims to provide information on the fertility journey including, but not limited to, preparing for conversations with specialists, highlighting potential treatment options and navigating cost and coverage Organon (NYSE: OGN) today announced the launch of a new website...

Postpartum hemorrhage is one of the most common complications of birth i Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the Jada&...

Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX), and Regeneron Pharmaceuticals (NASDAQ:REGN), respectively, the first, second, and fifth best performing pharma stocks of Q3 have not continued that positive momentum early in Q4. Since Oct. 1 through the close of trading today, Moderna is do...

It's time to look at the September 2021 period and look at how the portfolio performed. We saw an exciting dip, and as a result, significant buying opportunities. I took advantage and put almost $13,000 to work. Thanks to a truly massive extraordinary dividend from Swedish Handels...